FineTest
SKU(재고 관리 코드):FNab01657
anti- CHMP1B antibody
anti- CHMP1B antibody
Explore the fascinating world of endosomal sorting and cellular trafficking with our Anti-CHMP1B Antibody, available in a 100µg size. Charged multivesicular body protein 1B (CHMP1B) is a critical component of the ESCRT-III complex, playing a pivotal role in membrane remodeling and cargo sorting.
This high-quality antibody is meticulously crafted to offer exceptional specificity and sensitivity, ensuring accurate detection of CHMP1B protein in your experiments. Researchers investigating endosomal biology, membrane abscission, or related fields will appreciate the precision and reliability of this antibody.
Our Anti-CHMP1B Antibody undergoes rigorous quality control, guaranteeing consistent and reproducible results. Join the forefront of membrane biology research and uncover new insights into the mechanisms governing intracellular vesicle formation and membrane dynamics.
Product Name
CHMP1B antibody
Size
100µg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Host
Rabbit
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.)
BACKGROUND
CHMP1B belongs to the chromatin-modifying protein/charged multivesicular body protein (CHMP) family. These proteins are components of ESCRT-III (endosomal sorting complex required for transport III), a complex involved in degradation of surface receptor proteins and formation of endocytic multivesicular bodies (MVBs). Some CHMPs have both nuclear and cytoplasmic/vesicular distributions, and one such CHMP, CHMP1A (MIM 164010), is required for both MVB formation and regulation of cell cycle progression (Tsang et al., 2006 [PubMed 16730941]).
IMMUNOGEN INFORMATION
Immunogen
chromatin modifying protein 1B
Synonyms
C18orf2
Observed MW
30 kDa
APPLICATION
Tested Application
ELISA, WB, IHC
Recommended Dilution
WB: 1:500 - 1:2000; IHC: 1:50 - 1:100
UNIPROT INFORMATION
UniProt ID
IMAGES


Share
